左西替利嗪结构式
|
常用名 | 左西替利嗪 | 英文名 | Levocetirizine |
|---|---|---|---|---|
| CAS号 | 130018-77-8 | 分子量 | 388.888 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | 542.1±45.0 °C at 760 mmHg | |
| 分子式 | C21H25ClN2O3 | 熔点 | 205-208°C (dec.) | |
| MSDS | N/A | 闪点 | 281.6±28.7 °C |
左西替利嗪用途Levocetirizine ((R)-Cetirizine) 是第三代 peripheral H1-receptor 拮抗剂。Levocetirizine 是一种抗组胺药,是 Cetirizine 的 R 对映体。Levocetirizine 对组胺 H1-受体的亲和力高于 (S)-Cetirizine,并且可有效治疗变应性鼻炎和慢性特发性荨麻疹。 |
| 中文名 | 左西替利嗪 |
|---|---|
| 英文名 | Levocetirizine |
| 中文别名 | (R)-西替利嗪二盐酸盐 | 2-[2-[4-[(4-氯苯基)-苯基甲基]哌嗪-1-基]乙氧基]乙酸 |
| 英文别名 | 更多 |
| 描述 | Levocetirizine ((R)-Cetirizine) 是第三代 peripheral H1-receptor 拮抗剂。Levocetirizine 是一种抗组胺药,是 Cetirizine 的 R 对映体。Levocetirizine 对组胺 H1-受体的亲和力高于 (S)-Cetirizine,并且可有效治疗变应性鼻炎和慢性特发性荨麻疹。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
H1 receptor |
| 体内研究 | 左西替利嗪(0.4 mg/kg;口服;雄性Sprague-Dawley大鼠)治疗显示Cmax,AUC0-t,AUC0-∞和t1/2分别为0.34μg/mL,3.26μg h/mL,3.67μgh/mL和Sprague-Dawley大鼠分别为2.34小时[1]。动物模型:30只雄性Sprague-Dawley大鼠(8周龄;200-250g)[1]剂量:0.4mg/kg给药:口服给药(药代动力学分析)结果:Cmax,AUC0-t,AUC0-∞和t1/2分别为0.34μg/mL,3.26μg h/mL,3.67μgh/mL和2.34小时。 |
| 参考文献 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 542.1±45.0 °C at 760 mmHg |
| 熔点 | 205-208°C (dec.) |
| 分子式 | C21H25ClN2O3 |
| 分子量 | 388.888 |
| 闪点 | 281.6±28.7 °C |
| 精确质量 | 388.155365 |
| PSA | 53.01000 |
| LogP | 2.16 |
| InChIKey | ZKLPARSLTMPFCP-OAQYLSRUSA-N |
| SMILES | O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 |
| 外观性状 | 白色至米白色粉末或晶体 |
| 蒸汽压 | 0.0±1.5 mmHg at 25°C |
| 折射率 | 1.589 |
| 储存条件 | -20°C Freezer |
| 危害码 (欧洲) | Xn |
|---|---|
| 海关编码 | 2933599090 |
| 海关编码 | 2933599090 |
|---|---|
| 中文概述 | 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
实验名称:Primary cell-based high-throughput screening assay for identification of compounds th...
来源:Johns Hopkins Ion Channel Center
靶标:regulator of G-protein signaling 4 isoform 2 [Homo sapiens]
External Id:JHICC_RGS_Act_HTS
|
|
实验名称:Luminescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:mu-type opioid receptor isoform MOR-1 [Homo sapiens]
External Id:OPRM1-OPRD1_AG_LUMI_1536_1X%ACT PRUN
|
|
实验名称:Primary qHTS assay for small molecule inhibitors of Inositol hexaphosphate kinase 1 (...
来源:NCGC
External Id:IP6K1-p1
|
|
实验名称:QFRET-based biochemical primary high throughput screening assay to identify exosite i...
来源:The Scripps Research Institute Molecular Screening Center
靶标:disintegrin and metalloproteinase domain-containing protein 17 preproprotein [Homo sapiens]
External Id:ADAM17_INH_QFRET_1536_1X%INH PRUN
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:uHTS identification of small molecule activators of the adaptive arm of the Unfolded ...
来源:Burnham Center for Chemical Genomics
靶标:N/A
External Id:BCCG-A405-UPR-XBP1-PrimaryAgonist-Assay
|
|
实验名称:Cytochrome P450 family 3 subfamily A member 4 (CYP3A4) small molecule antagonists: lu...
来源:NCGC
External Id:CYP3A4437
|
|
实验名称:Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020);...
来源:ChEMBL
靶标:Staphylococcus aureus
External Id:CHEMBL4296184
|
|
实验名称:Cytochrome P450 family 2 subfamily D member 6 (CYP2D6) small molecule antagonists: lu...
来源:NCGC
External Id:CYP2D6395
|
|
实验名称:Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); ...
来源:ChEMBL
靶标:Klebsiella pneumoniae
External Id:CHEMBL4296186
|
| Levocetirizine [INN] |
| vardenafilH |
| Vivanza |
| MFCD04112703 |
| levocarnitine |
| (2-(4-((R)-(4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic Acid |
| (2-{4-[(R)-(4-Chlorophenyl)(phenyl)methyl]-1-piperazinyl}ethoxy)acetic acid |
| (2-{4-[(R)-(4-Chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid |
| Vardenafil |
| (-)-Cetirizine |
| levocetirizinum |
| (R)-Cetirizine |
| Levocetirizine |